Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Laboratory for Molecular Medicine, Mass General Brigham, Boston, Massachusetts, USA.
Hum Mutat. 2022 Aug;43(8):1114-1121. doi: 10.1002/humu.24317. Epub 2021 Dec 28.
The All of Us Research Program (AoURP) is a historic effort to accelerate research and improve healthcare by generating and collating data from one million people in the United States. Participants will have the option to receive results from their genome analysis, including actionable findings in 59 gene-disorder pairs for which disorder-associated variants are recommended for return by the American College of Medical Genetics and Genomics. To ensure consistent reporting across the AoURP, in a prelaunch study the four participating clinical laboratories shared all variant classifications in the 59 genes of interest from their internal databases. Of the 11,813 unique variants classified by at least two of the four laboratories, classifications were concordant with regard to reportability for 99.1% (11,711), with only 0.9% (102) having reportability differences. Through variant reassessment, data sharing, and discussion of rationale, participating laboratories resolved all 102 reportable differences. These approaches will be maintained during routine AoU reporting to ensure continuous classification harmonization and consistent reporting within AoURP.
美国全民研究计划(AoURP)是一项具有历史意义的努力,旨在通过从美国一百万人身上生成和整理数据来加速研究并改善医疗保健。参与者将可以选择获得他们基因组分析的结果,包括美国医学遗传学与基因组学学会推荐对 59 对与疾病相关的基因对中的可操作性发现进行回报的基因变异。为了确保 AoURP 中的报告一致,在预启动研究中,四个参与的临床实验室从他们的内部数据库中共享了感兴趣的 59 个基因中的所有变体分类。在至少有两个实验室分类的 11813 个独特变体中,关于报告的一致性为 99.1%(11711),仅有 0.9%(102)具有报告差异。通过变体重新评估、数据共享和讨论基本原理,参与的实验室解决了所有 102 个可报告的差异。这些方法将在常规的 AoU 报告中得到维护,以确保分类的持续协调和 AoURP 内的一致报告。